Varun's journey is an example of a leader with strategic planning, and hard work who transformed a legacy into a global ...

The theme this year for World Cancer Day, observed on February 4, 'United by Unique' is both, intriguing and relevant, as it ...

Varanasi: Banaras Hindu University (BHU) celebrated its 110th foundation day with vibrant spring colours on the occasion of ...

Strides Pharma Science in its consolidated financial results for the quarter Q3FY25 ended December 31, 2024 reported revenues of Rs. 1,153.7 crore with a growth 14.6% YoY in Q3FY25. The PAT stood at ...

Strides Pharma Science Ltd (BOM:532531) reports a robust quarter with 13.3% revenue growth and significant debt reduction, while navigating challenges in regulated markets.

Revenue increased 15% YoY at ₹1,153.7 crore from ₹1,005.8 crore in Q3 FY24, marking a consistent business growth.

Arun Kumar, Founder and Executive Chairperson of the Company, has served in various positions on the Board of Strides since its inception. His current appointment as Executive Director is expiring on ...

Strides Pharma Science is well on track to achieve the FY25 outlook of $275 million-$290 million, post-demerger.

The 76th Republic Day was celebrated by the various organisations with patriotic fervour, in Jammu. The Jammu Central Mahajan ...

Bangalore: Strides Pharma Science Limited has announced that the Company has received an ESG score of 76/100 and CSA score of ...